CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents	$ 106,614,708	$ 80,820,224
Restricted cash deposits		$ 63,677,610
Time deposits	$ 72,226,607
Accounts receivable, net of allowance for doubtful accounts	38,328,831	$ 19,402,820
Inventories	127,039,477	101,304,932
Prepayments and other current assets, net of allowance for doubtful accounts	27,789,090	14,781,658
Total Current Assets	371,998,713	279,987,244
Property, plant and equipment, net	91,208,433	80,230,888
Land use rights, net	15,837,832	11,909,136
Deposits related to land use rights	$ 12,822,069	12,792,355
Restricted cash and cash deposits, excluding current portion		40,230,250
Equity method investment	$ 9,825,728	18,221,777
Other non-current assets	3,236,260	3,475,442
Total Assets	$ 504,929,035	446,847,092
Current Liabilities
Short-term bank loans, including current portion of long-term bank loans		57,902,600
Accounts payable	$ 14,997,591	4,829,350
Other payables and accrued expenses	46,997,452	49,692,757
Income tax payable	6,775,105	8,257,133
Total Current Liabilities	$ 68,770,148	120,681,840
Long-term bank loans, excluding current portion		40,000,000
Deferred income	$ 2,626,321	2,765,024
Other liabilities	8,086,775	8,138,498
Total Liabilities	79,483,244	171,585,362
Stockholders' Equity
Common stock: par value $0.0001; 100,000,000 shares authorized; 27,962,705 and 27,865,871 shares issued at June 30, 2015 and December 31, 2014, respectively; 25,708,001 and 24,806,167 shares outstanding at June 30, 2015 and December 31, 2014, respectively	2,797	2,787
Additional paid-in capital	89,462,086	24,008,281
Treasury stock: 2,254,704 and 3,059,704 shares at June 30, 2015 and December 31, 2014, respectively, at cost	(56,425,094)	(76,570,621)
Retained earnings	294,547,822	244,661,391
Accumulated other comprehensive income	20,318,850	19,985,189
Total equity attributable to China Biologic Products, Inc.	347,906,461	212,087,027
Noncontrolling interest	77,539,330	63,174,703
Total Stockholders' Equity	$ 425,445,791	$ 275,261,730
Commitments and contingencies
Total Liabilities and Stockholders' Equity	$ 504,929,035	$ 446,847,092